Annual Dementia Treatment Expenditures Projected To Triple From $13 Billion In 2022 To $45 Billion By 2040

Spending on treatments for Alzheimer’s disease and related dementia (ADRD) in the United States is projected to triple between 2022 and 2040, from $12.8 billion to $45 billion (based on treatments available in 2019). By 2060, expenditures for ADRD treatment are projected to reach $102 billion (based on treatments available in 2019).

About 2.43 million people in the United States received treatment for ADRD in 2019 based on data reported on the 2019 Medical Expenditure Panel Survey. The Alzheimer’s Association estimates that 6.5 million people in the United States are living with diagnosed or undiagnosed . . .